United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - ranitidine (unii: 884kt10yb7) (ranitidine - unii:884kt10yb7) - ranitidine 15 mg in 1 ml - ranitidine syrup (ranitidine oral solution usp) is indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. - the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). - short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. - maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studie

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - magnesium hydroxide (unii: nbz3qy004s) (magnesium cation - unii:t6v3lhy838, hydroxide ion - unii:9159uv381p) - magnesium hydroxide 2400 mg in 10 ml - saline laxative - heartburn - upset/sour stomach - acid indigestion - relieves occasional constipation (irregularity) this product usually produces bowel movement in ½ to 6 hours.

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - bismuth subsalicylate (unii: 62tey51rr1) (bismuth cation - unii:zs9cd1i8ye) - bismuth subsalicylate 262 mg in 15 ml - upset stomach reliever and antidiarrheal relieves: - heartburn - indigestion - upset stomach - nausea - diarrhea (also relieves traveler's diarrhea and gas, belching, and fullness due to overindulgence with food and drink.)

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - loratadine (unii: 7ajo3bo7qn) (loratadine - unii:7ajo3bo7qn) - antihistamine temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: - runny nose - itchy, watery eyes - sneezing - itching of the nose or throat

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan (unii: 7355x3rots) (dextromethorphan - unii:7355x3rots) - guaifenesin 200 mg in 5 ml - - temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold - helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - acetaminophen 160 mg in 5 ml - pain reliever/fever reducer temporarily: - reduces fever - relieves minor aches and pain due to: the common cold flu headache sore throat toothache - the common cold - flu - headache - sore throat - toothache

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag) - docusate sodium 50 mg in 5 ml - stool softener - relieves occasional constipation (irregularity) - generally produces bowel movement in 12 to 72 hours

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt) - atovaquone oral suspension usp is indicated for the prevention of pneumocystis jirovecii pneumonia (pcp) in adults and adolescents (aged 13 years and older) who cannot tolerate trimethoprim-sulfamethoxazole (tmp-smx). atovaquone oral suspension usp is indicated for the acute oral treatment of mild-to-moderate pcp in adults and adolescents (aged 13 years and older) who cannot tolerate tmp-smx. clinical experience with atovaquone oral suspension usp for the treatment of pcp has been limited to subjects with mild-to-moderate pcp (alveolar-arterial oxygen diffusion gradient [(a-a)do 2 ] ≤45 mm hg). treatment of more severe episodes of pcp with atovaquone oral suspension usp has not been studied. the efficacy of atovaquone oral suspension usp in subjects who are failing therapy with tmp-smx has also not been studied. atovaquone oral suspension is contraindicated in patients who develop or have a history of hypersensitivity reactions (e.g., angioedema, bronchospasm, throat tightness, u

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precautions (5.1) for statement regarding fatal hepatic dysfunction. because of the risk to the fetus of decreased iq, neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless the drug is essential to the m

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate 2.5 mg in 5 ml - hydrocodone bitartrate and acetaminophen oral solution is indicated for the relief of moderate to moderately severe pain. this product should not be administered to patients who have previously exhibited hypersensitivity to hydrocodone, acetaminophen, or any other component of this product. patients known to be hypersensitive to other opioids may exhibit cross-sensitivity to hydrocodone. hydrocodone bitartrate and acetaminophen oral solution contains hydrocodone, an opioid agonist, and is a schedule iii controlled substance. hydrocodone bitartrate and acetaminophen oral solution, and other opioids used in analgesia can be abused and are subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. it is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving. drug addiction